Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Contingency management intervention is a structured, evidence-based behavioral therapy rooted in operant conditioning. It seeks to reinforce desired behaviors (such as drug abstinence) with immediate, tangible rewards—often cash, vouchers, or prizes—or to apply specified consequences to undesired actions[1][2][3][5][7][10]. CM is notably effective in addiction treatment, substantially increasing abstinence rates and treatment retention by leveraging the principles of reinforcement. Its use has expanded beyond substance use disorders to areas like mental health, criminal justice settings, and behavioral modification in other populations. CM is delivered in forms ranging from manual clinician-led programs to automated digital apps[4][6], but it remains a psychological/behavioral intervention, not a "druggable" biological target. Some ethical and practical concerns remain regarding its scalability and societal perceptions, but its effectiveness and safety are well-documented in a variety of clinical populations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Contingency management intervention.